1 recruiting. .
Follow Systemic AL Amyloidosis: new trials by email Literature Review of Systemic AL Amyloidosis trials Research Report on Systemic AL Amyloidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid dFLC Response Predict CHR in AL Amyloidosis Dara IV, Bortezomib (drug), Dexamethasone - Systemic AL Amyloidosis | Recruiting | Peking University People's Hospital | 50 | 2024-10-26 | 2026-03-09 |
Immunoglobulin Light-chain Amyloidosis (1)
Amyloidosis (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Metabolic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Nutritional and Metabolic Diseases (1) · Paraproteinemias (1) · Proteostasis Deficiencies (1)
Bortezomib (1) · Cyclophosphamide (1) · Dexamethasone (1) · Pharmaceutical Preparations (1)
Peking University People's Hospital (1)
China (1)